Abstract 1739: Preclinical profile of BAY 1163877 - a selective pan-FGFR inhibitor in phase 1 clinical trial
暂无分享，去创建一个
A. Haegebarth | M. Ocker | K. Ziegelbauer | M. Lobell | M. Héroult | P. Ellinghaus | Dirk Brohm | Stuart Ince | U. Boemer | M. Brands | H. Hess-Stumpp | R. Jautelat | Marie-Pierre Collin | C. Sieg | Sylvia Gruenewald | W. Huebsch